Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Cash from Operations (2020 - 2023)

Historic Cash from Operations for Pharming (PHAR) over the last 4 years, with Q2 2023 value amounting to -$32.4 million.

  • Pharming's Cash from Operations fell 91055.53% to -$32.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$32.4 million, marking a year-over-year decrease of 28856.5%. This contributed to the annual value of $7.1 million for FY2021, which is 9155.65% down from last year.
  • Per Pharming's latest filing, its Cash from Operations stood at -$32.4 million for Q2 2023, which was down 91055.53% from $609000.0 recorded in Q4 2022.
  • Pharming's 5-year Cash from Operations high stood at $17.2 million for Q3 2020, and its period low was -$32.4 million during Q2 2023.
  • Moreover, its 4-year median value for Cash from Operations was $609000.0 (2022), whereas its average is $1.3 million.
  • In the last 5 years, Pharming's Cash from Operations soared by 852484.07% in 2022 and then plummeted by 91055.53% in 2023.
  • Quarter analysis of 4 years shows Pharming's Cash from Operations stood at $87263.7 in 2020, then skyrocketed by 7991.57% to $7.1 million in 2021, then tumbled by 91.38% to $609000.0 in 2022, then tumbled by 5421.18% to -$32.4 million in 2023.
  • Its last three reported values are -$32.4 million in Q2 2023, $609000.0 for Q4 2022, and -$4.6 million during Q3 2022.